Literature DB >> 25221402

Effects of oxysophoridine on amino acids after cerebral ischemic injury in mice.

Tengfei Wang1, Yuxiang Li2, Peng Zhao1, Jie Wang3, Xiaomin Zhang3, Yinju Hao1, Juan Du1, Chengjun Zhao4, Tao Sun5, Jianqiang Yu6, Ru Zhou1, Shaoju Jin1.   

Abstract

BACKGROUND: Our previous studies demonstrated that oxysophoridine (OSR) had neuroprotective effects on mice through antioxidant and anti-apoptotic mechanisms. In this study, we investigated whether OSR could influence the release of amino acids in ischemic mice brains.
MATERIALS AND METHODS: Male ICR mice were scheduled to undergo 2 h middle cerebral artery occlusion (MCAO) and 24 h reperfusion. Before MCAO, mice in corresponding groups were intraperitoneally injected with OSR (62.5, 125 and 250 mg/kg) for seven successive days. After reperfusion, neurological scores were estimated, infarct volume and the brain water content were assessed. The levels of glutamate (Glu), aspartate (Asp), γ-aminobutyric acid (GABA) and Glycine (Gly) were measured by amino acid analyzer.
RESULTS: OSR significantly decreased neurological scores, reduced infarct volume and the brain water content. After treatment with OSR of 250 mg/kg, the contents of Glu, Asp, GABA and Gly in mice brains could maintain at a normal level compared with MCAO group mice. The Glu/GABA ratio was significantly decreased in OSR group mice.
CONCLUSION: These findings indicate that OSR has a protective effect on cerebral ischemic injury and helps to maintain the amino acids homeostasis after reperfusion for a long time.

Entities:  

Keywords:  Amino acids homeostasis; cerebral ischemic injury; excitatory amino acids; inhibitory amino acids; oxysophoridine

Year:  2014        PMID: 25221402      PMCID: PMC4162019          DOI: 10.4103/0972-2327.138513

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


Introduction

Cerebral ischemic injury is one of the most serious diseases which cause human death and disability in the world.[1] Excessive release of excitatory amino acids (EAA) is a primary pathological change in the process of cerebral ischemia reperfusion.[2] EAA are widely distributed in the neuron synapse, neuron soma and glial cell cytoplasm. Glutamate (Glu) and aspartate (Asp) are two important members of EAA and they are abundant in brain tissue. During the early stage of cerebral ischemia, excessive Glu and Asp may be released from neurons which play an important role in the pathways leading to cell death.[34] The view of Glu receptor antagonist can protect the cerebral ischemia injury is proved to be true in many studies.[567] Inhibitory amino acids (IAA), like γ-aminobutyric acid (GABA) and Glycine (Gly) can inhibit the excessive release of Glu. It is fully accepted that the imbalance between EAA and IAA causes cerebral ischemic injury.[8] Oxysophoridine (OSR), an alkaloid derivative based on sophoridine, is a natural alkaloid extracted from Sophora alopecuroides L. Sophora, its chemical structure is made of two piperidine rings [Figure 1]. From earlier researches, we demonstrated that OSR has protective effects on cerebral ischemic mice induced by middle cerebral artery occlusion through antioxidant and anti-apoptotic mechanisms.[910] In this study, we further investigated whether OSR could maintain the balance of EAA and IAA after a long time of reperfusion.
Figure 1

Structure of oxysophoridine (OSR)

Structure of oxysophoridine (OSR)

Materials and Methods

Animals and drug preparation

Male ICR mice (n = 85) aged from 4 to 5 weeks and weighed from 20.0 to 25.0 g were supplied by animal center of Ningxia Medical University. The experiments were performed as approved by the institutional animal care and use committee of Ningxia Medical University and all the efforts were made to minimize the suffering. Mice were randomly assigned to five groups: Sham-operated group (n = 17), vehicle group (n = 17), OSR 62.5, 125 and 250 mg/kg groups (n = 17 each group). Mice in OSR groups were intraperitoneally injected with OSR for seven successive days. OSR was supplied by the Institution of Chemistry and Chemical Engineering, Ningxia Medical University. Sham-operated and vehicle groups were treated with physiological saline under the same conditions.

Mice model of cerebral ischemia

The mice cerebral ischemic injury was induced by the model of middle cerebral artery occlusion as described by Longa et al.[11] After pretreatment with OSR or saline for seven days, mice in each group were anesthetized with 3.5% of chloral hydrate. Under sterile condition, the left common carotid artery (CCA) was exposed through a neck incision and the external carotid artery (ECA) was then isolated. The internal carotid artery (ICA) was separated carefully from the adjacent vagus nerve. Next, a nylon monofilament (15 mm in length and 0.15 mm in diameter) was introduced into the left ICA through the ECA stump to block the origin of the left middle cerebral artery (MCA). The monofilament was left in place for 2 h and then removed to restore blood flow for 24 h reperfusion. Mice in the sham-operated group were treated identically, except the MCA occlusion after the neck incision.

Evaluation of neurological deficits

Animals were examined for neurological deficits after 24 h of reperfusion using a five-point neurological function score described previously:[12] 0. No observable neurological deficit; 1. Unable to extend the right paw fully; 2. Circling to the right; 3. Falling to the right; 4. Being unable to walk spontaneously and depression of consciousness. All of these observations were performed by an investigator blinded to the identity of the groups.

Measurement of infarct volume

Following the neurological evaluation, mice (n = 6, for each group) were decapitated to remove brains. Then each brain was cut into 1 mm-thick slices. The brain slices were stained with 2% 2, 3, 5-triphenyltetrazolium chlorides (TTC) (Sigma, St Louis, MO, USA) at 37 °C for 30 min in the dark, and then transferred into 4% of formaldehyde for fixation. The unstained area of the brain slice was defined as infarction, and infarct volumes were calculated with microscope image-analysis software (Image-Pro plus, USA).

Assessment of brain edema

Mice (n = 6, for each group) were sacrificed after 24 h of reperfusion. The brains were divided into two hemispheres: The ischemic hemisphere (left side) and contralateral hemisphere. The ischemic hemisphere was weighed to obtain the wet weight and then dried at 110 °C for 24 h to measure the dry weight. The brain water content in the ischemic hemisphere was calculated as follows: Water content = (wet weight — dry weight)/wet weight × 100%.[13]

Free amino acids analysis

After 2 h of MCAO and 24 h of reperfusion, 5 mice from each group were decapitated. The brain tissues were collected and weighed, then homogenized in 8% 5-sulfosalicylic acid. The homogenate was centrifuged at 10,000 g for 15 minutes and was used to measure amino acids contents. Levels of amino acids were determined by an automatic amino acid analyzer (Model S-433D, sykam, Germany) according to the manufacturer's instructions.

Statistical analysis

Data are presented as mean ± SEM. Comparisons between groups were statistically evaluated by one-way ANOVA with a post hoc Fisher's test. Comparisons between two groups were assessed by unpaired t-test. A probability of P < 0.05 was considered to be statistically significant by SPSS 13.0 Statistical Software.

Results

Effects of OSR on cerebral ischemic injury in MCAO mice

After 2 h of MCAO and 24 h of reperfusion, the neurological deficits were significantly increased in the vehicle group mice compared to sham-operated group. OSR at the dose of 62.5, 125 and 250 mg/kg groups reduced the neurological deficit scores respectively [Table 1]. In vehicle group, the percentage of infarct volume was significantly increased (44.50 ± 1.10%, P < 0.01) compared with sham-operated group. In OSR treatment groups, the infarct volume was reduced to 39.06 ± 1.97% (P < 0.05) in OSR 62.5 mg/kg group and 36.32 ± 1.00% (P < 0.01) in OSR 125 mg/kg group and 22.44 ± 0.82% (P < 0.01) in OSR 250 mg/kg group [Table 2]. The brain water content, as an index of cerebral edema, was noticeably elevated from 79.96 ± 1.72% in sham-operated group to 86.54 ± 1.43% in vehicle group (P < 0.01). In OSR 62.5, 125 and 250 mg/kg group, the brain water content was decreased to 83.55 ± 1.02% (P < 0.01), 82.85 ± 0.78% (P < 0.01) and 80.08 ± 0.83% (P < 0.01) [Table 2]. All of these findings indicated that OSR can protect against cerebral ischemic injury in mice and the 250 mg/kg OSR group showed the best neuroprotective effect.
Table 1

Effects of OSR on neurological deficit scores induced by 2 h MCAO followed by 24 h reperfusion

Table 2

Effects of OSR on brain infarct volume and brain water content induced by 2 h MCAO followed by 24 h reperfusion

Effects of OSR on neurological deficit scores induced by 2 h MCAO followed by 24 h reperfusion Effects of OSR on brain infarct volume and brain water content induced by 2 h MCAO followed by 24 h reperfusion

Effects of OSR on amino acids contents

As shown in Figure 2, in sham-operated group, the contents of four amino acids in brain were Glu: 14.33 ± 1.17 μmol/g; Asp: 5.91 ± 0.33 μmol/g; GABA: 11.44 ± 1.09 μmol/g and Gly: 3.30 ± 0.25 μmol/g. After 2 h of ischemia and 24 h of reperfusion, content of Glu was markedly reduced to 10.46 ± 0.76 μmol/g and ASP level significantly decreased to 4.71 ± 0.25 μmol/g (P < 0.05) [Figure 2a and b]. The GABA content noticeably decreased to 6.23 ± 1.49 μmol/g (P < 0.05) and Gly level was similar to that of the sham-operated group [Figure 2c and d]. Pretreatment with 250 mg/kg OSR could increase all of these four amino acids levels. Glu, Asp, GABA and Gly contents increased to 13.01 ± 0.52 (P < 0.05), 5.03 ± 0.29, 10.40 ± 0.55 (P < .05) and 4.19 ± 0.18 μmol/g (P < 0.05) respectively.
Figure 2

Effects of OSR (250 mg/kg) on the contents of Glu, Asp, GABA and Gly in ischemic brain tissues. (a) Effect of OSR (250 mg/kg) on Glu levels in mice brains at 24 h after reperfusion. (b) Effect of OSR (250 mg/kg) on Asp levels in mice brains at 24 h after reperfusion. (c) Effect of OSR (250 mg/kg) on GABA levels in mice brains at 24 h after reperfusion. (d) Effect of OSR (250 mg/kg) on Gly levels in mice brains at 24 h after reperfusion. Data are expressed as mean ± SEM (n = 5). #P < 0.05 vs. shamoperated group; *P < 0.05 vs. vehicle group

Effects of OSR (250 mg/kg) on the contents of Glu, Asp, GABA and Gly in ischemic brain tissues. (a) Effect of OSR (250 mg/kg) on Glu levels in mice brains at 24 h after reperfusion. (b) Effect of OSR (250 mg/kg) on Asp levels in mice brains at 24 h after reperfusion. (c) Effect of OSR (250 mg/kg) on GABA levels in mice brains at 24 h after reperfusion. (d) Effect of OSR (250 mg/kg) on Gly levels in mice brains at 24 h after reperfusion. Data are expressed as mean ± SEM (n = 5). #P < 0.05 vs. shamoperated group; *P < 0.05 vs. vehicle group As representative amino acids of EAA and IAA, we further measured the ratio of Glu and GABA. In sham-operated group, Glu/GABA ratio was 1.31 ± 0.21. It was much higher in vehicle group than that of sham group (2.52 ± 0.34, P < 0.01). At OSR 250 mg/kg group, the ratio significantly reduced to 1.60 ± 0.19 (P < 0.05) [Figure 3].
Figure 3

Effects of OSR (250 mg/kg) on the changes of Glu/ GABA ratio in ischemic brain tissues. Data are expressed as mean ± SEM (n = 5). ##P < 0.01 vs. sham-operated group; *P < 0.05 vs. vehicle group

Effects of OSR (250 mg/kg) on the changes of Glu/ GABA ratio in ischemic brain tissues. Data are expressed as mean ± SEM (n = 5). ##P < 0.01 vs. sham-operated group; *P < 0.05 vs. vehicle group These findings demonstrated that OSR contributes to keep the amino acids homeostasis and maintain an equitable ratio of EAA/IAA in ischemic brain tissues.

Discussion

In the present study, cerebral ischemic injury in mice was induced by the model of middle cerebral artery occlusion. Our current findings revealed that cerebral ischemic injury could be greatly attenuated by OSR in vivo. In OSR 62.5, 125 and 250 mg/kg treatment groups, neurological scores, infarct volume and brain water content were decreased significantly, which of these demonstrated OSR could protect against cerebral ischemic injury. Amino acids, as important neurotransmitters in the central nervous system, play important roles in the information transmission between neurons. In the process of cerebral ischemia-reperfusion, metabolic disorder between excitatory amino acids (EAA) and inhibitory amino acids (IAA) causes acute neurons damage and intracellular calcium overload, which eventually leads to neuron death.[14] Glutamate (Glu) and aspartate (Asp) are important excitatory amino acids and γ-aminobutyric acid (GABA) and Glycine (Gly) are important inhibitory amino acids in brain. Glu can increase cortical cells activities and mediate excitatory synaptic transmission and excitotoxicity between central neurons. The contents of Glu and Asp will be markedly increased after cerebral ischemia-reperfusion, these changes further cause neurons death and apoptosis and then lead to acute brain injury. GABA can reduce cell injury through postsynaptic inhibition and decrease the release of Glu and eventually attenuate EAA induced toxicity. During the different time point of cerebral ischemia and reperfusion, the concentration of amino acids in ischemia region changed significantly by some previous studies.[1516] In this study, we measured the contents of Glu, Asp, GABA and Gly after 24 h of reperfusion, which is a relatively late time point. The results indicated that most of the amino acids levels were reduced at 24 h after reperfusion compared to normal standards. We consider that the excessive release of EAA and IAA at the early stages of cerebral ischemia leads to the low contents of amino acids after 24 h of reperfusion. OSR 250 mg/kg could inhibit the reduction of these four amino acids after cerebral ischemia reperfusion and help to maintain the contents of these four amino acids at a normal level. The imbalance of Glu/GABA ratio, is considered to regard as an important standard to promote the ischemic cerebral damage, was observed obviously in MCAO group mice. In the OSR 250 mg/kg group, the Glu/GABA ratio was significant lower. All of these findings indicated that OSR could maintain the amino acids homeostasis after 24 h of reperfusion. In this study, we did not measure the contents of these four amino acids at the early time of cerebral ischemia and reperfusion. At the early stages of cerebral ischemia, a large number of free amino acids were released in ischemic brains. According to some previous studies, we make a surmise that OSR could decrease the excessive release of free amino acids at the early time point of cerebral ischemia. The possible mechanisms may be associated with the effects that OSR enhance the free amino acids reuptake of neurons and inhibit the EAA excessive release. Our future study will measure these four amino acids’ contents at different time point after cerebral ischemia and reperfusion and wish to obtain a series of more convincing evidences to prove or revise our surmise.
  16 in total

Review 1.  Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.

Authors:  Marcus R Chacon; Matt B Jensen; Justin A Sattin; Justin A Zivin
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

2.  Anti-apoptotic and neuroprotective effects of oxysophoridine on cerebral ischemia both in vivo and in vitro.

Authors:  Chen Rui; Li Yuxiang; Jiang Ning; Ma Ningtian; Zhu Qingluan; Hao Yinju; Zhou Ru; Ma Lin; Sun Tao; Yu Jianqiang
Journal:  Planta Med       Date:  2013-06-27       Impact factor: 3.352

3.  Effects of glutamine treatment on myocardial damage and cardiac function in rats after severe burn injury.

Authors:  Hong Yan; Yong Zhang; Shang-jun Lv; Lin Wang; Guang-ping Liang; Qian-xue Wan; Xi Peng
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

4.  Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model for focal cerebral ischemia.

Authors:  L Bogaert; D Scheller; J Moonen; S Sarre; I Smolders; G Ebinger; Y Michotte
Journal:  Brain Res       Date:  2000-12-29       Impact factor: 3.252

Review 5.  Glutamate release and neuronal damage in ischemia.

Authors:  Y Nishizawa
Journal:  Life Sci       Date:  2001-06-15       Impact factor: 5.037

6.  Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.

Authors:  K Kawaguchi; S H Graham
Journal:  Brain Res       Date:  1997-02-21       Impact factor: 3.252

7.  Combination therapy with MK-801 and alpha-phenyl-tert-butyl-nitrone enhances protection against ischemic neuronal damage in organotypic hippocampal slice cultures.

Authors:  A Barth; L Barth; D W Newell
Journal:  Exp Neurol       Date:  1996-10       Impact factor: 5.330

8.  Effects of gastrodin on amino acids after cerebral ischemia-reperfusion injury in rat striatum.

Authors:  Xiaodong Bie; Yueqing Chen; Jinn Han; Haibin Dai; Haitong Wan; Tongfeng Zhao
Journal:  Asia Pac J Clin Nutr       Date:  2007       Impact factor: 1.662

Review 9.  Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia.

Authors:  J L Farber; K R Chien; S Mittnacht
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  1 in total

1.  Metabolite changes in the ipsilateral and contralateral cerebral hemispheres in rats with middle cerebral artery occlusion.

Authors:  Lei Ruan; Yan Wang; Shu-Chao Chen; Tian Zhao; Qun Huang; Zi-Long Hu; Neng-Zhi Xia; Jin-Jin Liu; Wei-Jian Chen; Yong Zhang; Jing-Liang Cheng; Hong-Chang Gao; Yun-Jun Yang; Hou-Zhang Sun
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.